Suri Rajinder Kumar, Liu Christina, Marini Aila
DCVMN International, 1025, Lotus Villas, Phase IV, DLF City, Gurgaon, Haryana 122009, India.
World Health Organisation, Switzerland.
Vaccine X. 2023 Jul 13;15:100353. doi: 10.1016/j.jvacx.2023.100353. eCollection 2023 Dec.
The 23rd Annual General Meeting of the Developing Countries Vaccine Manufacturers' Network (DCVMN), co-hosted by Serum Institute of India (SII), gathered over 365 delegates and more than 90 high-level speakers for three days of presentations, discussions, and networking, in Pune, India. The meeting provided a platform for vaccine manufacturers from developing countries to voice their experience, challenges and successes, as they play a critical role in the global research, development and supply of vaccines for achieving vaccine equity through increased collaborations and partnerships. The key topics of the 23rd Annual General Meeting revolved around: the key learnings from COVID-19, pandemic preparedness, vaccine sustainability and scalability, strengthening Africa's local manufacturing, partnerships & collaborations, financing, innovations, and vaccine hesitancy. The overarching theme focused on equity, timely access and sustainability, which was carried through in each session, with each panelist providing their contribution to answering - how can we create a sustainable vaccine ecosystem?
由印度血清研究所（SII）共同主办的发展中国家疫苗制造商网络（DCVMN）第23届年度大会在印度浦那举行，为期三天，吸引了365多名代表和90多名高级别演讲者参加，进行了演讲、讨论和交流。此次会议为发展中国家的疫苗制造商提供了一个平台，让他们能够分享自己的经验、面临的挑战和取得的成功，因为他们在全球疫苗研究、开发和供应中发挥着关键作用，通过加强合作与伙伴关系来实现疫苗公平。第23届年度大会的关键主题包括：新冠疫情的关键经验教训、大流行防范、疫苗的可持续性和可扩展性、加强非洲本土制造、伙伴关系与合作、融资、创新以及疫苗犹豫。总体主题聚焦于公平、及时获取和可持续性，这一主题贯穿于每一场会议，每位小组成员都为回答“我们如何创建一个可持续的疫苗生态系统？”贡献了自己的力量。
